Buy/Sell: Wall Street’s top 10 stock calls this week

What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts during the week of June 9-13. 

Find all top-rated stocks by the best-rated analysts on TipRanks.

Top 5 Buy Calls:

1. Stifel starts “super app” Uber with a Buy

Stifel initiated coverage of Uber (UBER) with a Buy rating and $110 price target. The firm “increasingly” views Uber as “a super app with multiple reasons to utilize the product,” including getting from point A to point B, ordering dinner and having groceries delivered, with “some ads seen along the way,” the firm tells investors. Stifel, which thinks Uber will be able to meet or exceed the three-year financial targets outlined in February 2024, also believes Uber will ultimately be successful in Delivery. The firm views Uber’s low advertising penetration as an opportunity.

2. Oracle upgraded to Outperform at BMO Capital

BMO Capital upgraded Oracle (ORCL) to Outperform from Market Perform with a price target of $235, up from $200. The firm cites the company’s “solid results and compelling guidance” for the upgrade. BMO now has growing confidence that Oracle can grow operating income dollars in fiscal 2026, and that price-to-earnings is a more appropriate valuation framework during accelerated capital expending spending periods. While Oracle’s fiscal 2026 remaining performance obligation guidance “seems aggressive,” even if the company is close to guidance, the shares will move higher, the firm tells investors in a research note. BMO believes the company’s software growth, including database, can improve, which will help mitigate margin/mix impact over time.

3. Wolfe upgrades Datadog to Outperform on AI growth opportunity

Wolfe Research upgraded Datadog (DDOG) to Outperform from Peer Perform with a $150 price target. The firm left the company’s DASH conference more confident in its near-term growth opportunity around artificial intelligence and remains confident in Datadog’s “market leading products driving long-term success.” The shares, after dropping 17% year-to-date, do not accurately reflect Datadog’s growth and margin profile as the company increased guidance to 20% year-over-year growth in 2025, which puts it in the “Heavyweight Growth peers” category, Wolfe tells investors in a research note. The firm models mid-20% growth in its “upside model” for this year with “durable” 20%-plus growth over the next three years.

4. First Solar upgraded to Buy at Jefferies

Jefferies upgraded First Solar (FSLR) to Buy from Hold with a price target of $192, up from $157. The firm says it is “time to get constructive again” on the shares. Jefferies increased earnings estimates for First Solar on higher average selling prices in 2028 and beyond. The firm sees upside to the estimates if new market pricing rises to the 32c-33c per watt range for new contracts. First Solar is “positioned to command a premium,” Jefferies tells investors in a research note. The firm sees utility-scale solar as the “most constructive” with the Inflation Reduction Act “still shaking out at the Senate level.” It expects First Solar to benefit from foreign entity of concern restrictions “keeping FEOC exposed suppliers at bay.”

5. TD upgrades Tapestry to Buy on continued Coach momentum

TD Cowen upgraded Tapestry (TPR) to Buy from Hold with a price target of $100, up from $90. The firm cites the continued brand momentum at Coach, the company’s $1B footwear opportunity, and its survey that indicates “strong brand heat and preferences” for the upgrade. Tapestry has globally diversified growth and customer data platform supporting a “marketing flywheel,” TD tells investors in a research note. The firm sees upside to the stock’s multiple. It left a recent meeting with management “incrementally positive” on the durability of Coach growth and the company’s overall pricing momentum.

Top 5 Sell Calls:

1. McDonald’s downgraded to Sell from Buy at Redburn Atlantic  

Redburn Atlantic double downgraded McDonald’s (MCD) to Sell from Buy with a price target of $260, down from $319. The firm sees the GLP-1 weight-loss drugs suppressing consumer appetites and presenting an underappreciated longer-term threat for McDonald’s. A 1% drag on sales today “could easily build to 10% or more over time,” particularly for restaurant brands skewed toward lower-income consumers, Redburn tells investors in a research note. The firm believes the impact of GLP-1 drugs will be cumulative and bring behavior changes that extend beyond an individual user, reshaping group dining and softening habitual demand.

2. Arete downgrades Etsy to Sell on advertising growth limitations

Arete downgraded Etsy (ETSY) to Sell from Neutral with a $43 price target. Third party data suggests the company’s gross merchandise sales improved in May, potentially turning positive after two years of decline, but Etsy is becoming more reliant on marketing for sales, the firm tells investors in a research note. In addition, the company is lapping one-off benefits and has reached the limitations of its advertising growth beyond one-time “growth hacks,” Arete tells investors in a research note. The firm downgrades the shares following the 50% rally since April.

3. Robinhood downgraded to Sell at Redburn Atlantic

Redburn Atlantic downgraded Robinhood (HOOD) to Sell from Neutral with a price target of $48, up from $40. The company “has executed a notable turnaround” while customer and deposit growth have reaccelerated, the firm tells investors in a research note. However, Redburn says the Robinhood bull case requires conviction that recent improvements are sustainable. There is some uncertainty around the company’s “moats,” adoption rates of new products and the durability of user engagement, contends the firm. Robinhood also derives a significant share of revenue from trading activity that is heavily geared into market cycles, it adds. Redburn also sees execution risk around the company’s global expansion and in integrating two acquisitions in new areas.

4. Deutsche downgrades Intuitive Surgical to Sell on I&A segment risk

Deutsche Bank downgraded Intuitive Surgical (ISRG) to Sell from Hold with a price target of $440, down from $515. Encroachment to Intuitive’s Instruments and Accessories segment by remanufactured instruments is inevitable and likely to be increasingly meaningful over the next few years, the firm tells investors in a research note. Deutsche expects a growing number of Intuitive’s customers to explore adoption of remanufactured instruments given the potentially significant profitability gains, citing its discussions with multiple robotic surgery programs. The firm believes 46% of Intuitive’s U.S. I&A revenues could be at risk of encroachment by third party-remanufactured devices. Its model assumes no material impact in 2026 but steadily increasing headwinds in 2027 and especially 2028.

5. Informa TechTarget downgraded to Underweight at JPMorgan

JPMorgan downgraded Informa TechTarget (TTGT) to Underweight from Neutral with a price target of $8, down from $18. After more than two months of delay, the company released its fiscal 2024 results, which were worse than expected, the firm tells investors in a research note. JPMorgan says that with more clarity on the combined performance and near-term prospects of the newly established company, it does not see Informa TechTarget as having attractive near-term investment characteristics. The firm does not see a near-term turning point or positive catalyst.